Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SQZ Biotechnologies (SQZB)
OTHER OTC:SQZB
Holding SQZB?
Track your performance easily
SQZB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.12
Previous CloseN/A
Volume166.00
Average Volume (3M)12.07K
Market Cap
$884.73K
Enterprise ValueN/A
Total Cash (Recent Filing)$106.91M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.16
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.43
Shares Outstanding29,491,125
10 Day Avg. Volume2,691
30 Day Avg. Volume12,066
Standard Deviation0.39
R-Squared0.03
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.07
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
5.49% Other Institutional Investors
94.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SQZB FAQ
What was SQZ Biotechnologies’s price range in the past 12 months?
SQZ Biotechnologies lowest stock price was $0.02 and its highest was $0.12 in the past 12 months.
What is SQZ Biotechnologies’s market cap?
SQZ Biotechnologies’s market cap is $884.73K.
When is SQZ Biotechnologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SQZ Biotechnologies’s earnings last quarter?
Currently, no data Available
Is SQZ Biotechnologies overvalued?
According to Wall Street analysts SQZ Biotechnologies’s price is currently Overvalued.
Does SQZ Biotechnologies pay dividends?
SQZ Biotechnologies does not currently pay dividends.
What is SQZ Biotechnologies’s EPS estimate?
SQZ Biotechnologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SQZ Biotechnologies have?
SQZ Biotechnologies has 29,491,125 shares outstanding.
What happened to SQZ Biotechnologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SQZ Biotechnologies?
Currently, no hedge funds are holding shares in SQZB
---
Company Description
SQZ Biotechnologies
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
---
Technical Analysis
---